Work

Phase I and IIa studies of simtuzumab alone and in combination with FOLFIRI in patients with advanced solid tumors.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.554

Authors: Patricia LoRusso, J. Randolph Hecht, Dung Luong Thai, Michael J. Hawkins, Hua Dong, Anthony W. Tolcher

Institutions: The Barbara Ann Karmanos Cancer Institute, University of California, Los Angeles, Gilead Sciences (United States), South Texas Accelerated Research Therapeutics

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591000693

Cites:

Cited by: 9

Related to: 10